Four major US medical organisations have joined efforts to promote a life-stage approach to women’s cardiovascular health, arguing that prevention and treatment should account for biological and health changes across a woman’s life. The framework was discussed in a November 20 report by JAMA, following a three-part publication in the journal Circulation.

Four Medical Societies Involved

The initiative brings together the American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine. The proposed framework considers cardiovascular health before menstruation, during reproductive years, through perimenopause and after menopause. JAMA’s report says the approach is intended to help clinicians recognise changes in risk that may be missed when care is based only on chronological age.

The framework highlights female-specific factors such as early or late menopause, menstrual irregularities, polycystic ovary syndrome, pregnancy complications, gestational diabetes and high blood pressure during pregnancy. These experiences can provide important information about a woman’s future cardiovascular health and may help identify opportunities for earlier prevention.

Why A Life-Course Approach Matters

Cardiovascular disease remains a leading cause of death among women, yet risk factors can be overlooked when care is divided among different medical specialties. Pregnancy, for example, may reveal previously unrecognised risks, while the transition through menopause can coincide with changes in cholesterol and metabolic health. The report notes that the new model is intended to encourage more coordinated care.

The guidance does not suggest that cardiovascular disease in women is caused only by hormones. Rather, it asks clinicians to consider biological transitions alongside established factors such as blood pressure, cholesterol, diabetes, smoking, physical activity and family history.

The authors also propose stronger infrastructure for specialised women’s cardiovascular care, including interdisciplinary centres that combine clinical services, education, research and community engagement. The framework is guidance for improving assessment and prevention; its success will depend on implementation, access to care and further evaluation. The full discussion is available in JAMA’s November 20 article.